Xlife Sciences Balance Sheet Health

Financial Health criteria checks 2/6

Xlife Sciences has a total shareholder equity of CHF367.0M and total debt of CHF55.2M, which brings its debt-to-equity ratio to 15%. Its total assets and total liabilities are CHF509.9M and CHF142.9M respectively.

Key information

15.0%

Debt to equity ratio

CHF 55.17m

Debt

Interest coverage ration/a
CashCHF 99.78k
EquityCHF 366.98m
Total liabilitiesCHF 142.88m
Total assetsCHF 509.86m

Recent financial health updates

No updates

Recent updates

Concerns Surrounding Xlife Sciences' (VTX:XLS) Performance

Sep 26
Concerns Surrounding Xlife Sciences' (VTX:XLS) Performance

Xlife Sciences' (VTX:XLS) Problems Go Beyond Weak Profit

Apr 28
Xlife Sciences' (VTX:XLS) Problems Go Beyond Weak Profit

Financial Position Analysis

Short Term Liabilities: XLS's short term assets (CHF17.9M) exceed its short term liabilities (CHF6.7M).

Long Term Liabilities: XLS's short term assets (CHF17.9M) do not cover its long term liabilities (CHF136.2M).


Debt to Equity History and Analysis

Debt Level: XLS's net debt to equity ratio (15%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if XLS's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: XLS's debt is not well covered by operating cash flow (3.5%).

Interest Coverage: Insufficient data to determine if XLS's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies